Prostate Cancer Detection with Multiparametric MRI: A Comparison of 1 M-Concentration Gadobutrol with 0.5 M-Concentration Gadolinium-Based Contrast Agents.

Current Urology
Takeshi HaraSusumu Kanazawa

Abstract

Gadobutrol (Gd-DO3A-butrol) (Gadovist®) is a macrocyclic gadolinium-based contrast agent for magnetic resonance imaging (MRI) formulated at 1.0 mmol Gd/ml. Gadobutrol's higher concentration compared to other contrast agents (0.5 mmol Gd/ml) is associated with higher T1 relaxivity. We examined whether gadobutrol increases the accuracy of prostate cancer detection using dynamic contrast-enhanced MRI. Multiparametric MRI was performed in 379 patients: 94 patients received 1 M gadobutrol while 285 randomly received equivalent doses of 0.5 M gadoterate meglumine or gadopentetate dimeglumine. MRI images were retrospectively and blindly assessed for the presence of cancer by comparing them with prostate biopsy findings. The specificity and accuracy were significantly higher with 1 M gadobutrol than 0.5 M of the other contrast agents. There were no significant differences in the sensitivity, or positive and negative predictive values. Multiparametric MRI using 1 M gadobutrol may improve the accuracy of prostate cancer detection.

References

Oct 19, 2005·Investigative Radiology·Martin RohrerHanns-Joachim Weinmann
Nov 30, 2006·European Radiology·Nicolas GirouinOlivier Rouvière
Sep 23, 2010·Diagnostic and Interventional Radiology : Official Journal of the Turkish Society of Radiology·Jin IwazawaShoichi Ohue
Sep 21, 2011·Radiology·Caroline M A HoeksJurgen J Fütterer
Feb 11, 2012·European Radiology·Jelle O BarentszUNKNOWN European Society of Urogenital Radiology
May 25, 2012·AJR. American Journal of Roentgenology·Sadhna VermaMukesh Harisinghani
Jul 28, 2013·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·T DurmusT Franiel
Jan 24, 2014·AJR. American Journal of Roentgenology·Maarten de RooijMaroeska M Rovers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.